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Abstract
LymPHOS is a web-oriented database containing peptide and protein sequences and
spectrometric information on the phosphoproteome of primary human T-Lymphocytes.
Current release 2.0 contains 15 566 phosphorylation sites from 8273 unique phosphopep-
tides and 4937 proteins, which correspond to a 45-fold increase over the original data-
base description. It now includes quantitative data on phosphorylation changes
after time-dependent treatment with activators of the TCR-mediated signal transduction
pathway. Sequence data quality has also been improved with the use of multiple search
engines for database searching. LymPHOS can be publicly accessed at http://www.lym
phos.org.
Database URL: http://www.lymphos.org.
Introduction
Regulation of cell function is mediated by changes in
protein activity, protein stability and protein–protein
interactions, through the action of a wide range of post-
translational modifications (PTMs). Over 460 PTMs are
described in the Uniprot database (http://www.uniprot.
org/docs/ptmlist), ranging from the attachment of small
compounds such as acetyl groups (acetylation) or phos-
phate groups (phosphorylation), to the addition of larger
molecules or peptide chains as in the cases of ubiquitina-
tion and glycosylation. The technological advances in
recent years, especially in mass spectrometry, have allowed
a more effective study of the proteome. In 2008,
UniProtKB/Swiss-Prot generated the first draft of the
human proteome including 20 000 protein-coding genes.
In 2013, spectrometric data repositories such as PRIDE
accumulated more than 30 000 experiments with nearly 7
million unique peptides identified in different species (1).
The establishment of these databases has promoted many
initiatives such as the Human Proteome Project (HPP),
which has among its objectives to sequence all proteins
encoded in the human genome (including modified forms),
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as well as to characterize protein interaction networks and
develop new specific antibodies (2).
While the sequencing of the human proteome is at a
well advanced stage, the case for PTM mapping remains
challenging. The technical issues of PTM analysis make
their coverage level still very low (3). The characterization
of these modifications is, however, vital for understanding
the cellular mechanisms involved in disease. The important
role of these processes in practice is evidenced by the
high number of regulatory modified proteins related to dis-
eases that are therapeutic targets of current or developing
drugs (4).
One of the most studied PTMs is protein phosphoryl-
ation. Characterizing phosphoproteome components and
their phosphorylation profiles in different conditions is
necessary to develop new drugs modulating the activity of
kinases and phosphatases. The importance of this area is
reflected by the presence of 150 kinase inhibitors cur-
rently in clinical trials, on top of the 20 that have already
been approved (5). This area alone is estimated to involve
a 30% of R&D expenditures in the pharmaceutical
industry.
The LymPHOS database was created in 2008 contain-
ing 342 p-sites from human primary T-lymphocytes (6).
To date, we have identified 15 566 phosphorylation sites in
a total of 8273 unique phosphopeptides belonging to 4937
proteins. About half of these sites have not been annotated
in UniProt experimentally or by similarity and over 200
are neither described in PhosphoSite (http://www.phospho
site.org), one of the most complete p-site collections avail-
able. Additionally, LymPHOS contains quantitative infor-
mation about changes in the phosphoproteome after cell
activation with Phorbol 12-myristate 13-acetate (PMA)
and ionomycin or with anti-CD3/CD28 monoclonal anti-
bodies. To our knowledge, there are no other resources
dedicated to phosphoproteome characterization of T-cells.
Management of LymPHOS is now achieved through an
automated workflow that includes MS data filtering, se-
quence identification by different search engines, phospho-
peptide quantification after time-dependent treatment,
accurate p-site assignation, and mass spectra visualization.
This report is a brief description of the improvements and
current status of this unique database.
Methods
Sample preparation
A total of 20 different qualitative and 11 quantitative ex-
periments are included in the database (see Experimental
section in the Lymphos2 website). In all cases, the starting
material were pools of T cells purified from 4 to 5 healthy
donors. For qualitative experiments one pool was used,
while quantitative experiments included two biological
replicates so that two different pools (i.e. 8–10 donors)
were utilized per experiment. Lymphocytes from each
donor were isolated from buffy coats through a density
gradient centrifugation using Ficoll-Paque (GE, Uppsala,
Sweden), followed by three washing steps to remove un-
wanted cellular contaminants and a 60 min plastic-adher-
ence culture to remove monocytes as described elsewhere
(7). Typically, a purity of ca. 80% in CD3þT lymphocytes
is achieved with this method. Cell stimulations were
carried out with PMA/Ionomycin or with anti-CD3/anti-
CD28 antibodies as previously described (8, 9). Protein ex-
tracts were digested with trypsin following standard
procedures or using the FASP method (10). For quantita-
tive purposes, tryptic peptides were labeled with iTRAQ or
TMT following manufacturer’s instructions. Samples were
then desalted by solid phase extraction (500 mg C18 Sep-
Pack cartridges, Waters, MA) and fractionated by strong
cation chromatography (SCX) using a Polysulfoethyl A
TM, 100 2.1 mm, 5 mm, 200 A˚ column. (PolyLC,
Columbia, MD). Each SCX fraction was then desalted by
solid phase extraction (15 mg, C18, Varian), evaporated to
near dryness and brought up to 200 mL with 250 mM ace-
tic acid/30% acetonitrile for subsequent phosphopeptide
enrichment. Phosphorylated peptides were enriched using
immobilized metal affinity chromatography (IMAC) and
titanium dioxide columns (TiO2) as performed in our pre-
vious studies (7, 11).
Mass spectrometric analysis
All the IMAC and TiO2 fractions were analyzed separately
by LC-MSn using an LTQ linear ion trap or an LTQ-
Orbitrap XL system equipped with a microESI ion source
(ThermoFisher, San Jose, CA). For qualitative studies, a
full MS scan followed by eight MS/MS scans on the most
abundant precursor signals were acquired. For quantitative
purposes, the three more abundant precursors from each
full MS were submitted to four MS/MS analyses (three
PQD and one CID scan) in the linear ion trap. Eight pre-
cursors per full scan were selected in the case of the LTQ-
Orbitrap each submitted to two different MS/MS analyses
(one CID and one HCD). In all cases, a subsequent MS3
scan was performed when a neutral loss of 49, 32.7 or
24.5 (loss of H3PO4 for theþ2,þ3 andþ4 charged ions,
respectively) was detected among the 10 most intense ions
in the CID MS/MS spectra. MS3 scans allow identification
of peptides with poor MS2 sequence data in qualitative
analyses. In quantitative analyses, MS3 scans also allow to
assign peptides with insufficient CID MS2 data but with
valid TMT or iTRAQ reporter ion data from the corres-
ponding PQD or HCD scans.
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Database search and phosphopeptide validation
The identification of phosphopeptides from mass spectra
was carried out following an automatic workflow de-
veloped in the laboratory, which is based on the use of dif-
ferent search engines in parallel (11). Using this strategy,
only peptide assignments pointed by at least two search en-
gines are considered as positive identifications. In order to
generate a well-matched generic input for the distinct search
engines (Sequest, OMSSA, EasyProt, Phenyx or PEAKS) the
original mass spectrometric data files (in the proprietary
Thermo Scientific .raw binary format) were converted and
split into two separate Mascot Generic Format (MGF) files
(for MS2 and MS3 data, respectively) using EasierMgf (12).
When processing quantitative data, EasierMgf also inserts
the intensities of the ions in the 100–150 Da range (which
contains the TMT or iTRAQ reporter ions) from the PQD
or HCD spectra into the corresponding CID spectra. All
searches were performed allowing a maximum ofþ4
charges for precursor ions and MS2 and MS3 spectra were
searched independently. Peptide mass tolerance was set to
2 Da and 20 ppm for linear ion trap and LTQ-Orbitrap, re-
spectively; fragment tolerance was set to 0.8 Da; enzyme
was set to trypsin, allowing up to one missed cleavage; static
modification was carbamidomethylated cysteine (þ57 Da);
dynamic modifications were methionine oxidation
(þ16 Da) and phosphorylation on Ser, Thr and Tyr
(þ80 Da). In MS3 searches, dehydration of Ser and Thr was
also taken into account.
Data from each search engine was aligned, homogenized,
and integrated using the Integrator software (12). Integrator
also determines the most probable phosphorylation site lo-
cation from the corresponding MS/MS data according to
the Q-Ascore algorithm. P-sites with Q-Ascore higher than
19 were considered of high confidence. Integrator produces
an output file (in JSON format) containing mass spectro-
metric and identification information and the adequate
structure to be uploaded to the LymPHOS database.
Quantitative analysis
TMT or iTRAQ reporter ion intensities were used for
quantitative analysis of the peptides identified by either
MS2 or MS3. The capability of using MS3 identifications
with MS2 derived quantification data is probably a unique
Figure 1. Schema of the database showing database main tables and fields (see Supplementary Figure S1 for details).
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Table 1. General information of LymPHOS database
Qualitative data
Spectra 60 323
Unique phosphopeptides 8273
All p-sites 15 566
(pSer j pThr j pTyr) (12 776 j 2494 j 296)
High-confidence p-sites 10 608
(pSer j pThr j pTyr) (9288 j 1194 j 126)
Phosphoproteinsa 4937/2596
Quantitative data
Spectra 7990
Unique phosphopeptides 2315
All p-sites 4763
(pSer j pThr j pTyr) (4169 j 545 j 49)
High-confidence p-sites 3959
(pSer j pThr j pTyr) (3556 j 366 j 37)
Quantified phosphoproteinsa 2272/1195
aAll the possible proteins identified from the sequence peptides/Minimal group of proteins defining the sequenced peptides.
Figure 2. Classical and JNK/p38 MAP kinase pathways (modified from KEGG pathways). Proteins for which one or more sites were detected phos-
phorylated in resting cells or cells after TCR activation are marked with a star. Filled stars indicate the observation of a significant phosphorylation
change after lymphocyte activation (P adj value< 0.05, 0.65 < fold change > 1.5). MAP kinases play a major role in the processing of the signals ori-
ginated by different external stimuli which ultimately trigger cell responses such as proliferation, cell division and differentiation and apoptosis (17,
18). Components of the MAP kinase pathway are central on the signal transmission pathways triggered by activation of the lymphocyte T receptor
including p38, which is activated by ZAP-70, or the components of the classical Ras/Raf/MEK/Erk MAP kinase cascade which activation involves the
proteins SOS and RasGRP (upper part of the graphic). Activation by SOS is directed by its translocation through the GRB2-LAT complexes, while
RasGRP is phosphorylated by PKC which in turn is activated by the DAG second messenger liberated by the activity of PLC-c (18).
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characteristic of our tools. Before the analysis, data was
normalized using the median of non-phosphorylated pep-
tide intensities. All of these steps are automatically per-
formed by our in-house developed PQuantifier software.
This application uses the normalized reporter ion intensity
values in order to calculate the ratio between each activa-
tion time and its respective control. For each identified
spectrum, PQuantifier assigns missing values, averages the
intensities of duplicate reporter ions, and calculates the
ratios for the different time points relative to the control.
For each experiment, PQuantifier normalizes these ratios
relative to the distribution of non-phosphorylated peptides
and calculates the peptide average ratios along the activa-
tion experiments. PQuantifier finally applies a t-test to de-
termine which peptides show significant changes. The final
results of the PQuantifier analysis, in JSON format, are up-
loaded onto the LymPHOS database.
Biological analysis
KEGG pathway analysis. Proteins for which one or more
sites were detected phosphorylated in resting or activated
cells were mapped to the KEGG pathways (13) using
DAVID Bioinformatics Resources 6.7 (http://david.abcc.
ncifcrf.gov) (14) and the whole Homo sapiens genome as
background.
Gene Ontology analysis. A Panther Database (version
10.0 Released 2015-05-15) statistical overrepresentation
test (release 20150430) was performed on the full
LymPHOS2 phosphoprotein contents and on the phospho-
protein subset containing regulated p-sites [http://pan
therdb.org/ (15, 16)]. The test was carried out using the
GO-slim terms for cellular compartment, molecular func-
tion and biological process. The reference protein list was
the full Homo sapiens proteome.
Database and web application structure
The LymPHOS web application consists of a relational data-
base and a web interface that allows data submission,
querying and visualization. The database uses MySQL
(http://www.mysql.com) as a relational database manage-
ment system. The web interface has been developed in
Python (http://www.python.org) using the Django web
framework (https://www.djangoproject.com), as well as other
well tested Python libraries, such as matplotlib (http://matplot
lib.org) and numpy (http://www.numpy.org) for the mass
spectrometry data visualization and analysis.
Additionally, several other small Python scripts were
created to populate the LymPHOS database with metadata
(experimental conditions, MIAPE data) and to export and
summarize its contained information. All source code for
LymPHOS, PQuantifier and the accessory scripts are avail-
able under an Open Source license, and can be freely
downloaded from our source code repository hosted at
Bitbucket (https://bitbucket.org/lp-csic-uab).
Results and discussion
The structure and characteristics of the original database
and web application was described in (6). Since then, the
Table 2. Quantitative data included in the LymPHOS database. Data for the full database (All) and for the set of high confidence
sequences (HC).
Upregulated Downregulated No change
15 min All S: 1586 j T: 179 j Y: 12 S: 461 j T: 70 j Y: 6 S: 1734 j T: 241 j Y: 18
HC S: 1380 j T: 120 j Y: 9 S: 397 j T: 51 j Y: 6 S: 1486 j T: 155 j Y: 14
120 min All S: 1596 j T: 194 j Y: 12 S: 560 j T: 63 j Y: 5 S: 1625 j T: 233 j Y: 19
HC S: 1402 j T: 134 j Y: 9 S: 485 j T: 52 j Y: 5 S: 1376 j T: 140 j Y: 15
240 min All S: 617 j T: 45 j Y: 1 S: 56 j T: 2 j Y: 5 S: 421 j T: 50 j Y: 15
HC S: 545 j T: 34 j Y: 1 S: 55 j T: 2 j Y: 5 S: 366 j T: 45 j Y: 10
Figure 3. Comparison of the fold-change (fc) values obtained using the
LymPHOS tools with those using the Dante package (18). For Dante ana-
lysis, each reporter ion had its values normalized against the median of
non-phosphorylated peptide intensities. n ¼ 1562 for each time point,
Coefficients of correlation r ¼ 0.98 (15 min) and r ¼ 1 (120 min).
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system has undergone significant changes with the imple-
mentation of new functions and features, especially those
related with the visualization of quantitative data and the use
of a sequence validation workflow based on the use of mul-
tiple search engines. As a consequence, the database schema
has grown from six tables holding 36 parameters to 12 core
and 5 auxiliary tables including a total of 117 fields (Figure 1
and Supplementary Figure 1). LymPHOS data has also been
under constant review, with various content updates, bug
fixes and additions of new experiments. Current data is
derived from the analysis of primary T cells obtained from
ca. 200 healthy donors along 31 different qualitative and
quantitative experiments.
Database contents
The new release of LymPHOS (http://lymphos.org, Table 1)
contains a total of 8273 unique phosphopeptides correspond-
ing to 2596 proteins (4937 when including isoforms).
The database describes 15 566 phosphorylation sites, 10 608
characterized with high confidence (ratio of phosphorylation
at Ser/Thr/Tyr: 88/11/1). These figures represent about a 45-
Figure 4. Quantitative summary. Example of the peptide SEsPKEPEQLR. Quantitative data for different p-sites is summarized using a visual presenta-
tion based on colored arrows.
Page 6 of 10 Database, Vol. 2015, Article ID bav115
fold increase over the original dataset in our 2009 publication
[342 phosphorylation sites, (6)] and has allowed us to map
lymphocyte key signaling pathways more extensively (Figure
2).
The most important improvements are related to data
quality and the addition of quantitative data. We imple-
mented a new workflow for peptide identification based
on the use of several search engines in parallel to increase
the number and confidence of identified sequences in our
datasets (11). As the different search engines use different
algorithms and scoring functions, identification of the
same sequence by more than one search engine greatly in-
creases the level of confidence in the match (19). Using this
approach, individual search results can be generated and
exported with minimal filtering. Assignations are then con-
sidered correct when identified by at least two search en-
gines, a selection that is carried out by the Integrator
application (12).
In addition, this version includes quantitative data for
more than 2300 phosphopeptides containing 3959 high
confidence p-sites which were quantified after activation at
15, 120 and 240 min (Table 2). Quantitative data has been
obtained using the PQuantifier application. This applica-
tion processes the Integrator output files (JSON format)
along with information about the experimental conditions
(cell treatment, labeling, activation times) to produce the
averaged change ratios between controls and activated
samples for each peptide. For each identified spectrum,
PQuantifier assigns missing values, averages the intensities
of duplicate reporter ions and calculates the ratios for the
different time points relative to the control. For each ex-
periment, PQuantifier normalizes these ratios relative to
the distribution of non-phosphorylated peptides and calcu-
lates the peptide average ratios along the activation
experiments.
Quantitative data produced with PQuantifier showed a
good correlation with the corresponding data obtained using
DanteR (20), a well-known software package with a different
workflow for data processing (Figure 3). Major differences
were observed in the quantitation from a few data points of
bad quality (peptide quantified from a single spectrum and
with many missing values). For example, when the two more
biased outliers were removed from the set on 1543 points
corresponding to the activation at 15 min, the coefficient of
correlation increased from 0.9842 to 0.9998. The output of
PQuantifier (JSON format), who uses itself a SQLite data-
base for intermediary storage of the processed data, is then
loaded into the MySQL database of the web application
Figure 5. Protein view. Example of the protein Serine/Arginine repetitive matrix protein 2. More than 100 p-sites were identified for this protein of
which only 1 showed statistically significant changes (insert). All phosphopeptides detected and quantified for the protein are shown in its sequence
with green (high confidence) or red (low confidence) background.
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LymPHOS. The web application stores this quantitative in-
formation, creates the required links between quantitative
data and the already stored mass spectrometry data, and per-
forms dynamic calculations for the visual presentation of the
observed changes. The quantitative data for different p-sites
is summarized using a convenient, straightforward visualiza-
tion that facilitates manual browsing and overviewing of the
available results (Figure 4). All of the identified and quanti-
fied p-sites of a given protein are collected in the protein view
(Figure 5).
Lymphocyte activation triggers intracellular signaling
cascades, mostly regulated by protein phosphorylation/
dephosphorylation events, which are ultimately respon-
sible of cellular processes such as cell migration, endocyto-
sis, cytokine liberation, proliferation, and apoptosis. An
analysis of overrepresented GO terms in our database rela-
tive to the human proteome (Figure 6) showed the collec-
tion of regulated proteins (yellow bar) grouped into
molecular functions and biological processes related to
these cell activities. Proteins involved in signal transduction
and cytoskeletal rearrangement were among the groups
with a higher overrepresentation. Terms referring to signal
transduction and phosphorylation processes include kinase
and protein kinase activities and protein phosphorylation
and cell communication processes. Morphological changes
in the cell were represented by several GO terms related to
cytoskeleton components, cytoskeletal binding proteins
and morphogenesis functions. Thus, many non-motor and
motor proteins associated to actin or the actin cytoskeleton
(dynein, plastin, lamin, myosin, paxilin, vimentin, plextrin
etc) were found regulated after cell activation. GO terms
represented in Figure 6 were filtered taking into account its
overrepresentation in the regulated subset of proteins. For
all these terms, the proportion of proteins contributing
from the full collection (green bar) was found smaller to
that of the regulated proteins. This difference was mainly
due to the subset of chromosome-associated phosphopro-
teins annotated in the database (grouped under the GO
terms protein–DNA complex, chromosome and chromo-
some-binding protein) as well as to extracellular matrix
proteins which are not regulated during activation (not
shown).
LymPHOS contribution to the human proteome
project
The human proteome project is an international endeavor
directed to the characterization of all the products encoded
in the human genome. This includes the identification and
quantification of proteins in healthy and pathological sam-
ples. HPP also aims to map specific PTMs of proteins. HPP
efforts are distributed among the different partners on a
chromosome per partner basis. In this context, LymPHOS
data is being integrated on the HPP project through the
Spanish Consortia which is in charge of the mining of
chromosome 16 (21, 22). LymPHOS data contributes both
to the description of new modification sites and of the
proteome of a primary cell. Despite the difficulties inherent
to the analysis of these cells in terms of availability and
amount of protein obtainable, data obtained from primary
cells is especially valuable as they would better represent
Figure 6. Gene Ontology (GO) enrichment analysis. Panther Database stat-
istical overrepresentation test for the full LymPHOS phosphoprotein data-
base (green) and the phosphoprotein set containing regulated p-sites
(orange) versus the reference human proteome (blue). Classification uses
GO-slim terms for cell compartment (A), biological process (B) and mo-
lecular function (C). Terms represented are those with enrichment> 1.5
and P < 0.01 for the subset of regulated proteins. Terms are sorted (left to
right) by increasing P value (http://pantherdb.org/).
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the lymphocyte physiological states than modified cell
lines.
The distribution of LymPHOS phosphoproteins based
on their chromosome localization is similar to that found
for the NextProt collection (23). The coverage of the pro-
tein-coding genome is of 10% and ranges from 7% to
14% depending on the chromosome. An exception is
chromosome Y for which a coverage of only 4% was ob-
tained (see Supplementary Figure S2). This could reflect
the contribution of both male and female donors as well as
the tissue specificity for the expression of many genes in
this chromosome. Chromosome 16 (chr16) is represented
with 90 phosphoproteins (52 of them with unique pep-
tides) and 466 phosphopeptides.
Conclusions
LymPHOS is an open access database for storage, sharing
and visualization of data related with the human T-
lymphocyte phosphoproteome. LymPHOS aims to provide
a complete set of experimental data including chromato-
graphic and spectrometric information. All MS2 and MS3
spectra justifying a p-site assignation are provided together
with the corresponding Sequest, OMSSA, Phenyx, Peaks or
EasyProt identification scores and p-site assignation scores
(Q-Ascore). The web-based user interface allows searching
phosphorylation sites on specific proteins and/or peptides
as well as browsing the entire database, in all cases having
experimental data to support each phosphorylation site
assignment.
Supplementary Data
Supplementary data are available at Database Online.
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